Pfizer Sees FY24 Adjusted Diluted EPS Guidance Range of $2.05-$2.25 Includes Expected Impact of Seagen Acquisition Versus Consensus Of $3.17
辉瑞预计,24财年调整后的摊薄后每股收益指导区间为2.05美元至2.25美元,其中包括收购希根的预期影响与共识3.17美元的影响
Pfizer Sees FY24 Adjusted Diluted EPS Guidance Range of $2.05-$2.25 Includes Expected Impact of Seagen Acquisition Versus Consensus Of $3.17
辉瑞预计,24财年调整后的摊薄后每股收益指导区间为2.05美元至2.25美元,其中包括收购希根的预期影响与共识3.17美元的影响
使用浏览器的分享功能,分享给你的好友吧